Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
IPO Year: 2013
Exchange: NYSE
Website: veeva.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/29/2025 | $270.00 → $300.00 | Buy | Needham |
| 1/23/2025 | $261.00 → $200.00 | Buy → Sell | Goldman |
| 12/20/2024 | $280.00 | Overweight | Stephens |
| 12/4/2024 | $275.00 | Outperform | Mizuho |
| 11/19/2024 | $235.00 | Sector Perform | Scotiabank |
| 10/8/2024 | $286.00 | Outperform | Exane BNP Paribas |
| 8/27/2024 | $256.00 → $273.00 | Buy | Citigroup |
| 7/9/2024 | $240.00 | Buy | BTIG Research |
| 10/25/2023 | $211.00 → $229.00 | Equal Weight → Overweight | Wells Fargo |
| 10/13/2023 | $265.00 | Buy | Jefferies |
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
144 - VEEVA SYSTEMS INC (0001393052) (Subject)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
DEF 14A - VEEVA SYSTEMS INC (0001393052) (Filer)
144 - VEEVA SYSTEMS INC (0001393052) (Subject)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
Fastest customizable press release news feed in the world
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250818883712/en/ The global partnerships make it easy for customers to work with IQVIA and Veeva in key areas including: Commercial: The companies
Nearly 70% say reducing manual processes is a key priority for working with sites PLEASANTON, Calif., Aug. 12, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced findings from the 2025 Veeva MedTech Clinical Benchmark, showing that medtech clinical teams are focused on streamlining work with research sites to reduce manual processes (68%), improve study quality (56%), and gain greater visibility and oversight (55%). The findings emphasize an opportunity to leverage technology to simplify and standardize clinical workflows, work more effectively with sites, and speed trials.
PLEASANTON, Calif., Aug. 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2025, after market close on August 27, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Second Quarter Results Conference Call Date: Wednesday, August 27, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registrati
Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif., July 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced findings from the 2025 Veeva Medtech Regulatory Affairs Benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations. Many organizations are manually reconciling data to ensure regulatory compliance, increasing the administrative burden for regulatory affairs teams. With the rise of new technology to streaml
PLEASANTON, Calif., July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 countries with Veeva OpenData and Veeva Network. Accurate and comprehensive customer reference data from OpenData will equip Boehringer Ingelheim's teams with the insights needed to engage healthcare professionals (HCPs) with relevant information, while laying the data foundation to scale AI. "Extending our trusted partnership with Veeva by adopting globally harmonized data will strengt
Deep application provides foundation for commercial execution PLEASANTON, Calif., July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Merck (NYSE:MRK), known as MSD outside of the United States and Canada, has committed to Veeva Vault CRM. The Vault CRM solution will support Merck as they enter one of the most significant launch periods in the company's history across a diverse set of new therapeutic areas and modalities. "We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," said Dave Williams, executive vice president
AWS compute, database, and global infrastructure support Veeva's industry cloud for life sciences Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), and Veeva Systems (NYSE:VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva is using AWS as the cloud infrastructure for its Veeva Vault applications, including Veeva Vault CRM Suite. More than 50 Veeva Vault applications and specialized data offerings such as Veeva Compass and Veeva CRM Pulse now use the proven security, performance, and scalability of AWS. Building on the long-standing AWS and
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to simplify and streamline medical device and diagnostics studies. With increasing regulatory requirements and evolving markets, medtech companies are moving away from siloed legacy solutions to modern connected applications from Veeva MedTech.
Industry focused on automation, connectivity, and reporting for proactive quality management PLEASANTON, Calif., June 9, 2025 /PRNewswire/ -- The 2025 Veeva MedTech Postmarket Quality Benchmark Report reveals that 88% of the medtech companies surveyed are advancing postmarket quality management within the next three years to improve compliance and drive innovation. This signals a shift toward modernization to reduce risk and foster a stronger culture of quality across the product lifecycle. While the move to more scalable solutions is planned or underway for most, 68% of medte
Vault CRM will support Astellas' commercial agility and execution PLEASANTON, Calif., June 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Astellas has chosen Veeva Vault CRM globally and Veeva China CRM for China. "At Astellas, we discover and deliver transformative therapies for patients around the world," said Nick Eshkenazi, chief digital and transformation officer at Astellas. "Having a foundation for commercial agility and execution is crucial. Our collaboration with Veeva will provide us with technology solutions and data to enhance our agility as a co
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Needham reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $300.00 from $270.00 previously
Goldman downgraded Veeva Systems from Buy to Sell and set a new price target of $200.00 from $261.00 previously
Stephens initiated coverage of Veeva Systems with a rating of Overweight and set a new price target of $280.00
Mizuho initiated coverage of Veeva Systems with a rating of Outperform and set a new price target of $275.00
Scotiabank initiated coverage of Veeva Systems with a rating of Sector Perform and set a new price target of $235.00
Exane BNP Paribas initiated coverage of Veeva Systems with a rating of Outperform and set a new price target of $286.00
Citigroup reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $273.00 from $256.00 previously
BTIG Research initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $240.00
Wells Fargo upgraded Veeva Systems from Equal Weight to Overweight and set a new price target of $229.00 from $211.00 previously
Jefferies initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $265.00
Live Leadership Updates
PLEASANTON, Calif., Jan. 25, 2022 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced the appointments of Tim Cabral, Priscilla Hung, Tina Hunt, and Marshall Mohr to its board of directors. Veeva also announced Ron Codd will retire from the board at the end of his current term in June 2022. "We are pleased to welcome Tim, Priscilla, Tina, and Marshall, who bring a range of experience in life sciences and enterprise software to the Veeva board," said Veeva CEO Peter Gassner. "I would also like to thank Ron Codd for a decade of partnership and contributions to Veeva." Th
BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its certificate of inc
PLEASANTON, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT CORPORATION Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majorit
PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With today’s shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its ce
Live finance-specific insights
PLEASANTON, Calif., Aug. 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2025, after market close on August 27, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Second Quarter Results Conference Call Date: Wednesday, August 27, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registrati
Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif., May 28, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025. "I consider this our best first quarter ever. We executed with speed, quality, and innovation across all areas on short-term objectives and long-term initiatives aligned to our values and 2030 goals," said CEO Peter Gassner. "Thanks t
PLEASANTON, Calif., May 7, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter, which ended April 30, 2025, after market close on May 28, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 First Quarter Results Conference Call Date: Wednesday, May 28, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: https:/
Fiscal Year 2025 Total Revenues of $2,746.6M, up 16% Year Over YearQ4 Total Revenues of $720.9M, up 14% Year Over Year Fiscal Year 2025 Subscription Services Revenues of $2,284.7M, up 20% Year Over YearQ4 Subscription Services Revenues of $608.6M, up 17% Year Over Year PLEASANTON, Calif., March 5, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2025. "It was an outstanding quarter and year of execution and i
PLEASANTON, Calif., Feb. 12, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2025, after market close on March 5, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2025 Fourth Quarter and Full Year Results Conference Call Date: Wednesday, March 5, 2025 Time: 2:00 p.m. PT (5:00 p.m
Total Revenues of $699.2M, up 13% Year Over YearSubscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the board," said CEO Peter Gassner. "Especially significant was the hard work for the long term. We deepened a number of large, highly strategic relationships and a
PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its third quarter, which ended October 31, 2024, after market close on December 5, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2025 Third Quarter Results Conference Call Date: Thursday, December 5, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registr
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif., Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024. "It was another quarter of great execution, with major product advances in clinical and CRM that position us well for the industry cloud opportunity we see ahead," said CEO Peter Gassner. "Thanks to the team's focus on product excell
PLEASANTON, Calif., Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2025 Second Quarter Results Conference Call Date: Wednesday, August 28, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: htt
Total Revenues of $650.3M, up 24% Year Over Year;Subscription Services Revenues of $534.0M, up 29% Year Over Year PLEASANTON, Calif., May 30, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2024. "Thanks to our customers and the Veeva team we had an excellent start to the year," said CEO Peter Gassner. "We made major progress in Development Cloud, Commercial Cloud, and Data Cloud." Fiscal 2025 First Quarter Results: Revenues(1
This live feed shows all institutional transactions in real time.
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)